/CERS

Cerus Corp

CERS

$2.49USD↑+1.22%+0.03 today

MARKET CAP

501.8M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$2 – $3

52W RANGE

$1

$3

AI Summary

Stalk

StalkMedium

CERS remains in a Stage 2 advancing uptrend, preserving higher highs above the rising 50 DMA. However, recent rejection at the 9 and 21 EMAs and a short-term downtrend suggest timing is unfavorable now. A pullback toward the rising EMAs or the 50 DMA support region would present a higher-probability entry opportunity.

↑Q2 product revenue $57.4 M (+10% YoY); full-year 2026 guidance $229–231 M (+10–12%)
↑Operating expenses down 7% YoY; adjusted EBITDA more than tripled
↓Operating cash flow –$2.7 M raises near-term liquidity concerns

Full analysis →

Buying

5

institutions

Selling

3

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	22.22 M	64.87 M	+639.71 K	+65.2%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	1.88 M	5.48 M	+-234.96 K	+42.6%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	843.78 K	2.46 M	+655.18 K	+617.8%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	671.70 K	1.96 M	+92.80 K	+86.2%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	BUYNEW	228.17 K	666.26 K	+228.17 K	+0.0%	0.00%
MM Millennium Management LLC Q2 2026	SELL	108.48 K	316.76 K	+-321.74 K	-59.5%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	89.06 K	266.29 K	+9.38 K	+93.2%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-26.88 K	-100.0%	0.00%